Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Optinose Plans To Effect 1-For-15 Reverse Stock Split At 5:00 P.M. Eastern Standard Time, On December 30, 2024

Author: Benzinga Newsdesk | December 26, 2024 08:05am

Beginning with the opening of trading on December 31, 2024, Optinose's common stock will trade on the Nasdaq Global Select Market on a split-adjusted basis under a new CUSIP number 68404V209 and Optinose's existing trading symbol "OPTN."

The reverse stock split is intended to enable Optinose to regain compliance with the $1.00 minimum closing bid price required for continued listing on Nasdaq.


 

Posted In: OPTN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist